在双重诊断的抑郁症中使用德克斯特罗米多芬-布普组合:从一系列病例的见解
Mahak Aggarwal1, Jawahar Singh1, Khushpreet Kaur1
1Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Bathinda, Punjab, India.
Indian journal of psychiatry
|March 9, 2026
概括
德克斯特罗米多芬-布普罗组合显示出治疗主要抑郁障碍与同时出现的物质使用障碍的前景. 这种新的治疗方法为双重诊断的患者提供了希望,这些患者没有对传统抗抑郁药做出反应.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 重度抑郁症 (MDD) 与同时出现的物质使用障碍 (SUD) 构成了重大的临床挑战.
- 患者经常经历无情,复发率高,对标准抗抑郁药疗法的反应有限.
- 德克斯特罗梅多芬和布洛普的组合提供了一种针对谷氨酸和多巴胺基通路的新型治疗方法.
研究的目的:
- 评估德克斯特罗梅索芬-布普罗组合在患有抑郁症和物质使用障碍双重诊断的患者中的疗效.
- 报告治疗耐药性抑郁症和同时出现的酒精或阿片类药物依赖症患者的临床结果.
主要方法:
- 三名被诊断患有酒精或阿片类药物依赖和并发性抑郁症的男性患者的病例系列介绍.
- 患者在多次先前抗抑郁药试验失败后接受了德克斯特罗梅索芬-布普罗组合治疗.
主要成果:
- 这三名患者都在抑郁症症状上显著改善.
- 患者还显示整体功能得到改善.
- 尽管以前使用常规抗抑郁药治疗失败,但观察到这些积极的结果.
结论:
- 德克斯特罗米多芬-布普罗组合似乎是双重诊断抑郁症的可行治疗选择.
- 需要进一步的受控研究来证实这种联合治疗的疗效和安全性.
- 这种治疗可能为治疗耐药抑郁症与伴随性物质使用障碍的复杂病例的管理提供了一条新途径.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Antidepressant Drugs: Overview
1.8K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.8K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.9K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.9K
Depressive Disorders: MDD and Dysthymia
964
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
964
Drug Therapy
360
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
360
Sedatives and Hypnotics Drugs: Miscellaneous Agents
749
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
749


